Scaling up Biodefense

The US is ramping up its capabilities for producing vaccines and other medical countermeasures to respond to epidemics, pandemics, and bioterrorism events through a $440 million initiative that is funding three centers around the country, called the Centers for Innovation in Advanced Development and Manufacturing program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.